View Older Stories

Apr 7, 2026 06:02AM Oppenheimer on TransMedics Group (TMDX): 'Concerns on Jet Fuel Costs Misplaced'

Mar 16, 2026 09:37AM TD Cowen Reiterates Buy Rating on TransMedics Group (TMDX): new label to be a 'preview of soon-to-be-published data'

Mar 9, 2026 07:57AM TransMedics Group (TMDX) PT Raised to $130 at Stifel: Remains 'Least Confident Hold'

Mar 9, 2026 07:57AM TransMedics Group (TMDX) PT Raised to $130 at Stifel: Remains Least Confident Hold'

Feb 27, 2026 07:01AM TransMedics clarifies tax valuation allowance impact on Q4 results

Feb 25, 2026 07:11AM TransMedics Group (TMDX) PT Raised to $174 at Needham

Feb 24, 2026 04:11PM TransMedics Group (TMDX) Tops Q4 EPS by $2.23, provides guidance

Feb 9, 2026 08:02AM TransMedics gets FDA approval for heart transplant trial

Feb 4, 2026 04:21PM TransMedics Group appoints Giovanni Cecere as chief commercial officer

Jan 21, 2026 03:41PM TransMedics stock falls after Bridge to Life wins FDA clearance for liver device

Jan 6, 2026 07:48AM TransMedics Group (TMDX) Reiterated at Hold by Stifel: Comp Headwinds Ahead

Jan 2, 2026 12:27AM Piper Sandler Reiterates Overweight Rating on TransMedics Group (TMDX)

Dec 22, 2025 07:02AM Piper Sandler on TransMedics Group (TMDX): 'NG Heart Trial Could Deliver Meaningful Upside'

Dec 8, 2025 06:26AM TransMedics Group (TMDX) PT Raised to $166 at Needham

Oct 30, 2025 06:34AM TransMedics Group (TMDX) PT Raised to $147 at Canaccord Genuity

Oct 30, 2025 04:50AM Needham Reiterates Buy Rating on TransMedics Group (TMDX)

Oct 29, 2025 04:13PM TransMedics Group (TMDX) Tops Q3 EPS by 30c, provides guidance

Oct 23, 2025 05:49AM Needham Upgrades TransMedics Group (TMDX) to Buy

Oct 14, 2025 07:13AM Stifel Reiterates Hold Rating on TransMedics Group (TMDX); Notes Share, End Market Weakness

Oct 13, 2025 02:12AM Jefferies Starts TransMedics Group (TMDX) at Buy

Oct 7, 2025 06:13AM Evercore Adds Names to TAP Lists

Sep 16, 2025 06:13AM Evercore ISI Starts TransMedics Group (TMDX) at Outperform

Sep 3, 2025 04:07PM Stifel Starts TransMedics Group (TMDX) at Hold

Aug 29, 2025 08:09AM TD Cowen Reiterates Buy Rating on TransMedics Group (TMDX)

Aug 4, 2025 08:01AM TransMedics gets FDA approval to start heart preservation trial

Jul 30, 2025 04:16PM TransMedics Group (TMDX) Tops Q2 EPS by 47c ; Offers Guidance

Jul 15, 2025 06:19AM TransMedics Group (TMDX) PT Raised to $142 at Canaccord Genuity

Jun 24, 2025 09:40AM TD Cowen's Best Smidcap Ideas 2025

Jun 17, 2025 06:03AM TransMedics Group (TMDX) PT Raised to $150 at Oppenheimer

Jun 4, 2025 08:30AM TransMedics Group (TMDX) PT Raised to $145 at Piper Sandler

May 9, 2025 06:02AM TransMedics Group (TMDX) PT Raised to $130 at Oppenheimer

May 8, 2025 04:25PM TransMedics Group (TMDX) Tops Q1 EPS by 44c ; Offers Guidance

May 1, 2025 04:50PM Kuehn Law Encourages Investors of TransMedics Group, Inc. to Contact Law Firm

Apr 28, 2025 01:29PM Canaccord Genuity Reiterates Buy Rating on TransMedics Group (TMDX)

Apr 15, 2025 12:07PM Scott+Scott Attorneys at Law LLP Alerts Investors There Is an Ongoing Securities Class Action Against TransMedics Group, Inc. (TMDX)

Apr 14, 2025 12:32PM TMDX DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action First Filed by the Firm -

Apr 14, 2025 12:04PM Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against TransMedics Group, Inc. (TMDX)

Apr 14, 2025 09:37AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TransMedics Group

Apr 14, 2025 08:07AM TMDX STOCK UPDATE: TransMedics Group Investors are Reminded to Contact BFA Law before the Expiration of Tomorrow's April 15 Class Action Deadline

Apr 13, 2025 04:00PM TMDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Apr 13, 2025 12:03PM Scott+Scott Attorneys at Law LLP Continues to Remind Investors of The Ongoing Securities Class Action Against TransMedics Group, Inc. (TMDX)

Apr 13, 2025 09:09AM TMDX IMPORTANT DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action First Filed

Apr 12, 2025 12:01PM Scott+Scott Attorneys at Law LLP Reminds Investors a Securities Action Has Been Filed Against TransMedics Group, Inc. (TMDX)

Apr 11, 2025 03:18PM TMDX STOCK ALERT: BFA Law Alerts TransMedics Group Investors of the Imminent April 15 Class Action Deadline

Apr 11, 2025 01:50PM TMDX DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages TransMedics Group, Inc. Investors with Losses in Excess of $50K to Secure Counsel Before Important April 15 Deadline in Securities Class

Apr 11, 2025 12:05PM Scott+Scott Attorneys at Law LLP Alerts Investors of The Pending Securities Class Action Against TransMedics Group, Inc. (TMDX)

Apr 10, 2025 12:00PM Scott+Scott Attorneys at Law LLP Reminds Investors of The Securities Class Action That Has Been Filed Against TransMedics Group, Inc. (TMDX)

Apr 10, 2025 09:33AM TUESDAY INVESTOR DEADLINE: TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TMDX

Apr 10, 2025 07:46AM TMDX CLASS REMINDER: TransMedics Group Investors are Reminded to Contact BFA Law about the Pending Class Action by the April 15 Court Deadline

Apr 9, 2025 07:30PM TMDX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages TransMedics Group, Inc. Investors to Secure Counsel Before Important April 15 Deadline in Securities Class Action First Filed by the Firm

View Older Stories